Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin

American Journal of Ophthalmology

Volumn 136, Issue 5, 2003, Pages 836-845

  Chan, Wai Man ^a,b   Lam, Dennis S C ^a,b,c   Lai, Timothy Y Y ^a   Yuen, Kenneth S C ^b   Liu, David T L ^b   Chan, Carmen K M ^a   Chen, Wei Qi ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Jt Shantou International Eye Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAOCULAR HEMORRHAGE; MALE; OUTCOMES RESEARCH; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 0142195789     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00462-8     Document Type: Article

References (48)

1. Yannuzzi L.A., Shakin J.L., Fisher Y.L., Altomonte M.A. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology. 91:1984;1554-1572.
2. Gass J.D., Norton E.W., Justice J. Jr. Serous detachment of the retinal pigment epithelium. Trans Am Acad Ophthalmol Otolaryngol. 70:1966;990-1015.
3. Akiyama K., Kawamura M., Ogata T., Tanaka E. Retinal vascular loss in idiopathic central serous chorioretinopathy with bullous retinal detachment. Ophthalmology. 94:1987;1605-1609.
4. Schatz H., Osterloh M.D., McDonald H.R., Johnson R.N. Development of retinal vascular leakage and cystoid macular oedema secondary to central serous chorioretinopathy. Br J Ophthalmol. 77:1993;744-746.
5. Ie D., Yannuzzi L.A., Spaide R.F., et al. Subretinal exudative deposits in central serous chorioretinopathy. Br J Ophthalmol. 77:1993;349-353.
6. Sharma T., Badrinath S.S., Gopal L., et al. Subretinal fibrosis and nonrhegmatogenous retinal detachment associated with multifocal central serous chorioretinopathy. Retina. 18:1998;23-29.
7. Lip P.L., Mowatt-Dixon L., Hope-Ross M.W. Central serous retinopathy complicated by massive bilateral subretinal haemorrhage. Br J Ophthalmol. 83:1999;990-991.
8. Laatikainen L., Hoffren M. Long-term follow-up study of nonsenile detachment of the retinal pigment epithelium. Eur J Ophthalmol. 1:1991;79-84.
9. Nadel A.J., Turan M.I., Coles R.S. Central serous retinopathy A generalized disease of the pigment epithelium . Mod Probl Ophthalmol. 20:1979;76-88.
10. Marmor M.F. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 226:1988;548-552.
11. Guyer D.R., Yannuzzi L.A., Slakter J.S., et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 112:1994;1057-1062.
12. Prunte C., Flammer J. Choriodal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 121:1996;26-34.
13. Piccolino F.C., Borgia L., Zinicola E., Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye. 9:1995;324-332.
14. Spaide R.F., Hall L., Haas A., et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina. 16:1996;203-213.
15. Scheider A., Nasemann J.E., Lund O.E. Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol. 115:1993;50-56.
16. Nishiyama Y., Mori K., Murayama K., Yoneya S. Quantitative analysis of indocyanine green angiographic image in central serous chorioretinopathy. Jpn J Ophthalmol. 45:2001;116.
17. Giovannini A., Scassellati-Sforzolini B., D'Altobrando E., et al. Choroidal findings in the course of idiopathic serous pigment epithelial detachment detected by indocyanine green videoangiography. Retina. 17:1997;286-293.
18. Yannuzzi L.A., Freund K.B., Goldbaum M., et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology. 107:2000;767-777.
19. Castro-Correia J., Coutinho M.F., Rosas V., Maia J. Long-term follow-up of central serous retinopathy in 150 patients. Doc Ophthalmol. 81:1992;379-386.
20. Jalkh A.E., Jabbour N., Avila M.P., et al. Retinal pigment epithelium decompensation. I. Clinical features and natural course. Ophthalmology. 91:1984;1544-1548.
21. von Ruckmann A., Fitzke F.W., Fan J., et al. Abnormalities of fundus autofluorescence in central serous retinopathy. Am J Ophthalmol. 133:2002;780-786.
22. Levine R., Brucker A.J., Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology. 96:1989;854-859.
23. Loo R.H., Scott I.U., Flynn H.W. Jr, et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. 22:2002;19-24.
24. Bandello F., Virgili G., Lanzetta P., et al. ICG angiography and retinal pigment epithelial decompensation. J Fr Ophtalmol. 24:2001;448-451.
25. Gomolin J.E. Choroidal neovascularization and central serous chorioretinopathy. Can J Ophthalmol. 24:1989;20-23.
26. Matsunaga H., Nangoh K., Uyama M., Nanbu H., Fujiseki Y., Takahashi K. Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy. Nippon Ganka Gakkai Zasshi. 99:1995;460-468.
27. Gass J.D. Photocoagulation treatment of idiopathic central serous choroidopathy. Trans Am Acad Ophthalmol Otolaryngol. 83:1977;456-467.
28. Cooper B.A., Thomas M.A. Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol. 130:2000;187-191.
29. Gass J.D.M. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 118:1994;285-289.
30. Husain D., Kramer M., Kenny A.G., et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci. 40:1999;2322-2331.
31. Schmidt-Erfurth U., Michels S., Barbazetto I., Laqua H. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci. 43:2002;830-841.
32. Schmidt-Erfurth U., Miller J.W., Sickenberg M., et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration Results of retreatments in a phase 1 and 2 study . Arch Ophthalmol. 117:1999;1177-1187.
33. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin One-year results of 2 randomized clinical trials - TAP report 1 . Arch Ophthalmol. 117:1999;1329-1345.
34. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin 1-year results of a randomized clinical trial - VIP report no . 1. Ophthalmology. 108:2001;841-852.
35. Laser photocoagulation for juxtafoveal choroidal neovascularization Five-year results from randomized clinical trials . Arch Ophthalmol. 112:1994;500-509.
36. Holladay J.T. Proper method for calculating average visual acuity. J Refract Surg. 13:1997;388-391.
37. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration Updated findings from two clinical trials . Arch Ophthalmol. 111:1993;1200-1209.
38. Guyer D.R., Yannuzzi L.A., Slakter J.S., Sorenson J.A., Hope-Ross M., Orlock D.R. Digital indocyanine-green videoangiography of occult choroidal neovascularization. Ophthalmology. 101:1994;1727-1735.
39. Fernandes L.H., Freund K.B., Yannuzzi L.A., et al. The nature of focal areas of hyperfluorescence or hot spots imaged with indocyanine green angiography. Retina. 22:2002;557-568.
40. Berger A.R., Olk R.J., Burgess D. Central serous choroidopathy in patients over 50 years of age. Ophthalmic Surg. 22:1991;583-590.
41. Yannuzzi L.A. Type-A behavior and central serous chorioretinopathy. Retina. 7:1987;111-131.
42. Spaide R.F., Campeas L., Haas A., et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 103:1996;2070-2079.
43. Iida T., Kishi S., Hagimura N., Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina. 19:1999;508-512.
44. Chappelow A.V., Marmor M.F. Multifocal electroretinogram abnormalities persist following resolution of central serous chorioretinopathy. Arch Ophthalmol. 118:2000;1211-1215.
45. Saperstein D.A., Rosenfeld P.J., Bressler N.M., et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome one-year results of an uncontrolled, prospective case series . Ophthalmology. 109:2002;1499-1505.
46. Spaide R., Martin M., Slakter J., et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol. 134:2002;62-68.
47. Argon laser photocoagulation for idiopathic neovascularization Results of a randomized clinical trial . Arch Ophthalmol. 101:1983;1358-1361.
48. Lindblom B., Andersson T. The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age. Ophthalmology. 105:1998;1816-1820.